在北印度人群中进行的结核性脑膜炎A病例控制研究中,循环MicroRNA作为诊断指标
Ritika1, Vineeta Singh2, Varun Kumar Singh3
1Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, Uttar Pradesh, India.
概括
结核性脑膜炎 (TBM) 中的微RNA显示出改变的表达,其中特定的分子如hsa-miR-23b-5p和hsa-miR-126-5p可能作为诊断生物标志物. 在TBM诊断和监测中需要进一步的研究.
科学领域:
- 分子生物学
- 基因组学
- 传染性疾病
背景情况:
- 结核性脑膜炎 (TBM) 是一种严重的结核病,死亡率高,神经复杂性严重.
- 微RNAs (miRNAs) 越来越多地被认为是TBM病原和潜在的诊断生物标志物.
研究的目的:
- 在TBM患者中识别差异表达的miRNA.
- 探索这些miRNA作为TBM诊断和疾病进展的生物标志物的潜力.
主要方法:
- 对8名TBM患者和3名健康对照进行了全血RNA测序.
- 通过使用 edgeR 来识别差异表达的miRNA,并从数据库中检索验证的miRNA- mRNA相互作用.
- 使用clusterProfiler和KEGG进行了功能丰富和途径分析.
主要成果:
- 四种miRNAs (hsa- miR- 23b- 5p,hsa- miR- 27a- 5p,hsa- miR- 126-5p,hsa- miR- 339-5p) 在TBM中表现出显著的差异.
- 观察到特定阶段的miRNA表达模式,hsa- let- 7f- 5p和hsa- miR- 16-5p在第二阶段的TBM上调.
- 丰富的生物过程包括细胞周期调节和RNA剪接;关键途径涉及自和内细胞分裂.
结论:
- 鉴定出差异表达的miRNAs显示为早期TBM诊断和监测的生物标志物.
- 要将这些发现转化为临床实践,需要进行大规模的验证研究.
更多相关视频
13:36Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
19.5K
15:28A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
7.9K
相关概念视频
Pulmonary Tuberculosis IV
202
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
202
Pulmonary Tuberculosis III
439
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
439
